{
  "ticker": "RMD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967004",
  "id": "02967004",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250708",
  "time": "0822",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06lkvwx13k1wy2.pdf",
  "summary": "- **Form 144 Filing (Insider Sale):**  \n  - **Seller:** Michael J. Farrell (Officer/Director of ResMed Inc.)  \n  - **Securities Sold:** 8,009 common shares (NYSE: RMD)  \n  - **Aggregate Market Value:** ~$2.06M AUD (converted from USD)  \n  - **Approximate Sale Date:** 07/07/2025 (planned)  \n  - **Recent Sales (Past 3 Months):**  \n    - 08/07/2025: 8,009 shares ($1.68M)  \n    - 05/07/2025: 8,009 shares ($1.95M)  \n    - 06/09/2025: 8,009 shares ($2.01M)  \n  - **Rule 10b5-1 Plan:** Adopted 10/31/2024 (prearranged trading plan)  \n\n*Note: Filing indicates no undisclosed material adverse information about ResMed as of the plan adoption date.*",
  "usage": {
    "prompt_tokens": 1327,
    "completion_tokens": 225,
    "total_tokens": 1552,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-07T22:38:05.802748"
}